SPONSOR
Qilu Pharmaceutical Co., Ltd.
Total Trials
5
Recruiting
5
Phases
Phase 3, Phase 4, Phase 1, Phase 2, Phase 1
Conditions studied: Relapsed or Refractory Multiple MyelomaTransthyretin Amyloid PolyneuropathyChemotherapy-induced Peripheral Neuropathy (CIPN)Advanced Solid TumorInfections
NCT07138209 Phase 3
Recruiting
A Study Comparing QLS32015 Monotherapy Versus Pomalidomide, Dexamethasone (Pd) or Selinexor, Dexamethasone (Sd) in Participants With Relapsed or Refractory Multiple Myeloma
Relapsed or Refractory Multiple Myeloma
NCT06940336 Phase 4
Recruiting
To Evaluate the Efficacy and Safety of Tafamidis Meglumine Soft Capsules in the Treatment of Adult Patients With Transthyretin Amyloid Polyneuropathy
Transthyretin Amyloid Polyneuropathy
NCT06994507 Phase 3
Recruiting
GM1 Prophylaxis for Nab-paclitaxel-associated Chemotherapy-induced Peripheral Neuropathy (CIPN) in Patients With Breast Cancer
Chemotherapy-induced Peripheral Neuropathy (CIPN)
NCT06911827 Phase 1, Phase 2
Recruiting
A Study of QLP2117 in Combination With QL2107 in Advanced Solid Tumor Patients
Advanced Solid Tumor
NCT07124468 Phase 1
Recruiting
Assess the Plasma, Epithelial Lining, and Alveolar Macrophage Concentrations of Intravenous Meropenem-Pralubactam (Meropenem/FL058) in China Healthy Adult Participants
Infections